ADVISORY BOARD

Dermot G. Coughlan, F.C.C.A. - U.K.

Mr. Coughlan is Chairman and Chief Executive Officer of Derland Holdings Inc., a private investment holding company which also provides mergers and acquisition services and consulting services to the aerospace industry worldwide. He is Chairman of Global Equipment Solutions Ltd, a private company that procures oil-related commodities for clients internationally. Mr Coughlan is also currently a Non-Executive Director for African Minerals. He was born in Oxfordshire, England and served in the Royal Air Force. He is a Chartered Certified Accountant.

Mr. Coughlan has held positions with Rio Tinto Zinc Corporation PLC and also with Alcan Industries and Cavenham Foods. From 1970 to 1983 he was President and CEO of Canada-based Indal Limited, a public company, and during that time built it into a major corporation manufacturing products for global aerospace, engineering and construction markets. He has held directorships in several publicly listed companies including CCL industries, Mackenzie Financial, Hayes-Dana Corporation, Crown Life Insurance Company, and The Dee Corporation PLC. He has served as Chair of Audit, Human Resources or Governance Committees for CCL Industries, Mackenzie Financial, and Hayes-Dana. Mr. Coughlan currently provides mergers, acquisitions and consulting advice to major industrial, aerospace and technology companies worldwide. He also provides commodity transactions services to major companies in Europe, Asia and South America..

James Bernstein, M.D.

Dr. Bernstein is the Managing Partner of AMBER ADVISORY, a business development and advisory company, as well as an Entrepreneurship Coach with the Kaufman Foundation. He is Chairman and Director of Health Programs for Walkabout Development Solutions International, which develops sustainable health programs for isolated and underserved areas in developing countries. He has over 30 years of entrepreneurial general management experience including serving as CEO, Chairman and founder of Noxilizer, Inc, a privately held company that is pioneering the development and commercialization of a superior room temperature gas sterilization system for next generation resorbable implants and drug device combinations. Prior experience includes: founding and helping launch the biotechnology company Adlyfe, which is developing novel diagnostics for Alzheimer’s disease; founding and building bioinformatics start-up Informax, which he took public in 2000, raising $80 million, and founding Pharmaservice, a wholesale distribution company for pharmaceuticals in Russia. In 1976, Dr. Bernstein launched his first company, General Health, Inc., a health risk estimation business, which was an Inc. 500 company two years in a row and pioneered individual data driven publishing and health promotion (wellness) at the work site.

Dr. Bernstein served as a Special Expert Consultant to the Director of the National Heart Lung and Blood Institute with responsibility for maintaining and promoting physician competence. He also served as the Deputy Director of the Georgetown University Health Policy Center, where he chaired President Carter’s health policy advisory group during his first campaign for President.

A graduate of Harvard College and Cornell Medical School, Dr. Bernstein, trained in general and transplantation surgery, has served on and chaired the Boards of several other diverse companies in life sciences and strategic marketing. He lectures on Entrepreneurship (Tuck, University of Maryland, Georgetown) serves as a Fast-Trac advisor (Kaufman Foundation) and advises start-up businesses. He is Board Chairman of COUNTERPOINT, a vibrant chamber orchestra in the DC area. He is a cellist and an avid gardener. He is married to a prominent social entrepreneur and is the father of three daughters, a son and is a grandfather.

Nelson Blitz, Esq.

Mr. Blitz is the co-founder of Executive Counsel and has a unique and extensive combination of experiences. Having practiced law for over 20 years, Mr. Blitz has been in senior executive management and board of director roles as General Counsel and Corporate Secretary, Senior Vice President for Corporate Development and Chief Risk Officer for global information technology services and outsourcers, James Martin + Company and Headstrong Corporation.

In addition, Nelson was a senior partner in a major Washington D.C. area law firm, where he represented national and international technology, telecommunications, distribution, retail and building industry clients. His legal experiences include handling Corporate, Transactional and Governance matters, Intellectual Property, Business Controversies and International matters in more than 14 countries.

In his role as Director of Corporate Development for James Martin + Co. and Headstrong Corporation, Nelson was the senior executive responsible for raising $191,000,000 from premier private equity groups, Welsh Carson Anderson and Stowe and H&Q Asia Pacific. He identified, structured and closed a number of acquisitions in the U.S., Europe and Asia. As Chief Risk Officer, he was responsible for implementing and operating commercial, legal and delivery risk management for multi-million dollar technology delivery, offshore and outsourcing projects.

In 2001, Mr. Blitz spoke before the International Finance Corporation's (IFC) Annual Meeting. He also spoke for the Northern Virginia Technology Counsel CFO Series - "Raising Capital in Difficult Times" and for various other legal, community, charitable and commercial organizations. In addition he has been quoted in several national business publications including, The Wall Street Journal and The Daily Deal.

Stig Bøgh Karlsen

Stig Karlsen has been head of NOKA Holding A/S, a venture company engaged in shaping venture development in Denmark.

In the early part of his career, Mr. Karlsen was for a long time the CEO of Magasin du Nord, a leading Scandinavian Department Store Group. He joined the AEGIS Group in 1992 and developed the activities of CARAT in Scandinavia and the Baltic countries, so that it became the leading media buying and planning company in the area. In 1996 he moved to New York as head of strategy to build up Carat in North America. In the course of his time there Carat acquired 7 regional companies in USA and Canada to form Carat North America, which is now one of the leading media-buying and planning companies in the region. He handed it over to a US management team before returning to Denmark in 2001.

Tapan Gandhi, CFA

Tapan Gandhi is the President of Forward Thinking, which is based in Mumbai, India. Tapan has more than 15 years of international professional experience in business, finance, strategy, investing, and complex M&A transactions. He has extensive experience advising senior business leaders at top Fortune 100 Companies to create sustainable and profitable business models by formulating organic and inorganic growth strategies. He excels at strategic thinking, understanding/evaluating industries and identifying winning and profitable business models. Tapan has a proven track record in leading complex and highly structured transactions to achieve strategic and financial goals, having worked on more than 200 deals. Tapan is a CFA charter holder and holds an MBA from Yale University and a Masters in Management Studies from Mumbai University. Tapan was most recently the Head of Corporate Development & Strategy for Lehman Brothers India and has been associated with other world-class organizations like Booz & Co. (former name: Booz Allen Hamilton), Philips, Capital One, and Hong Kong Bank amongst others.

Vasilis Voudouris, PhD, MBA

Vasilis Voudouris is the CEO and Founder of Vereniki Solutions, a consulting firm in the San Francisco Bay Area focusing on providing services to the biotech, pharma and chemical industry. Dr. Voudouris has over 18 years of both domestic and international experience in large corporations (Bayer, Dow, Genentech, Eli Lilly) and small start-ups. Dr. Voudouris's areas of expertise include business and technology assessments, biotech and pharmaceutical manufacturing, process development, supply chain management and technical operations. His experience covers biologics, small molecules and combination products as well as industrial and fine chemicals. Previously, Dr. Voudouris led the Process Engineering Department at Nektar Therapeutics, where he validated the Exubera commercial manufacturing process. He also played a key role in the development and manufacturing of combination products and helped form the business strategy to enable commercialization of Nektar's technology platform. Prior to Nektar Therapeutics, he was Head of Biochem Production Services at Genentech where he was responsible for coordinating the day to day activities in one of the world's largest biotechnology facilities. Dr. Voudouris also has had roles of increasing responsibility at Bayer both in the US and German/global headquarters where he spent 5 years through an expatriate assignment.